Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
Status:
Suspended
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This study aims to study the effects that two standard of care immunosuppression induction
regimens have on regulatory T cells (Treg) in live donor renal transplant recipients. Both
regimens are currently used in this hospital for early immunosuppression induction but the
effects on Treg numbers and function is not well understood and likely will impact long term
immune function.